logo
Parimal Trivedi

Parimal Trivedi

Director

Parimal Trivedi is a highly accomplished scientist and gold medalist with over 20 years of experience in drug discovery and development. With a strong background in medicinal chemistry, he has played a pivotal role in advancing pharmaceutical research while working with leading multinational companies, including Torrent Pharmaceuticals. His expertise spans the synthesis of complex organic molecules, impurity profiling, and process development, making him a trusted partner for global pharmaceutical and biotech industries.
As the Director of HexaSynth Technologies Private Limited, Parimal leads a team of experts dedicated to delivering high-quality research solutions in custom synthesis, reference standards, and drug development. His deep understanding of synthetic chemistry, coupled with a commitment to innovation, ensures that HexaSynth remains at the forefront of pharmaceutical R&D.
Education:
Master's in Medicinal Chemistry, St. Xavier's College, Gujarat University
Core Expertise

  • Drug Discovery & Development

    Extensive experience in leading discovery projects, designing novel compounds, and accelerating early-stage drug candidates.

  • Synthesis of Complex Organic Molecules

    Specialization in designing and synthesizing diverse compound libraries for pharmaceutical research.

  • Impurity Profiling & Reference Standards

    Expertise in synthesizing and characterizing pharmacopoeial/non-pharmacopoeial impurities, reference standards, and working standards.

  • Process Development & Optimization

    Skilled in feasibility studies, process optimization, and developing cost-effective, scalable synthetic routes.

  • Technology Transfer & Manufacturing Support

    Proven ability to transfer processes from R&D to commercial-scale manufacturing with high efficiency.

  • Analytical Characterization & Structure Elucidation

    Advanced knowledge in isolating, characterizing, and elucidating complex process- and formulation-related impurities.

With a track record of scientific excellence, industry experience, and a global outlook, Parimal Trivedi continues to drive innovation at HexaSynth Technologies, helping clients worldwide achieve breakthroughs in drug development and pharmaceutical research.
Dr. Atul Bhartiya

Dr. Atul Bhartiya

Director & CMO

Dr. Atul Bhartiya is an established pharmaceutical scientist with over 25 years of experience in Analytical Research, specializing in unknown impurity isolation and characterization, solid-state characterization and regulatory compliance. As the Director of HexaSynth Technologies Private Limited, he leads cutting-edge research in pharmaceutical analysis and custom synthesis, offering innovative solutions for the industry.
Dr. Bhartiya holds an M.Sc. (ICA) and a Ph.D. in Analytical Chemistry. He has been associated with renowned global pharmaceutical companies such as Lupin, Glenmark, Wockhardt, and Torrent, where he played a pivotal role in complex formulation development and regulatory approvals. His expertise spans across solid-state characterization techniques like XRD, FTIR, Raman, and NIR, as well as impurity isolation and structural elucidation using advanced spectroscopic methods (1H, 13C, and 2D NMR).
Expertise & Key Contributions
Impurity Isolation & Characterization: Extensive experience in HPLC, GC, LC-MS/MS, NMR, IR, and other high-end analytical techniques for impurity profiling and drug substance analysis.

  • Publication

    His publication in journals like Journal of Pharmaceutical and Biomedical Sciences.

  • Regulatory Approvals & Compliance

    Contributed to the successful ANDA and DMF approvals for global markets, including the US, EU, Brazil, and India. Well-versed in regulatory requirements for US FDA, EMA, and other international agencies.

  • Nitrosamine Impurity Analysis

    Specialized in method development and validation of nitrosamine impurities in drug substances and products using LC-MS/MS and GC-MS/MS for sartan and non-sartan molecules.

  • Analytical Method Development & Validation

    Expertise in method development, validation, transfer, and QC support, ensuring cGMP compliance and regulatory readiness.

  • Leadership & Team Management

    Proven ability to lead large analytical teams, manage projects efficiently, and handle regulatory queries to drive successful drug approvals.

Leadership at HexaSynth Technologies:
At HexaSynth Technologies, Dr. Bhartiya spearheads research and innovation in impurity synthesis, analytical method development, and pharmaceutical R&D. Under his leadership, the company provides custom synthesis of complex impurities, drug metabolites, and pharmacopoeial reference standards, supporting domestic and international regulatory requirements.
His scientific acumen, regulatory expertise, and strategic vision continue to shape the success of challenging pharmaceutical product development, making him a key contributor to advancing drug research and quality standards in the industry.